Delivering Positive Newborn Screening Results: Cost Analysis of Existing Practice versus Innovative, Co-Designed Strategies from the ReSPoND Study.
View / Open Files
Authors
Holder, Pru
Bonham, James R
Southern, Kevin W
Simpson, Alan
Olander, Ellinor K
Morris, Stephen
Publication Date
2022-03-14Journal Title
Int J Neonatal Screen
ISSN
2409-515X
Publisher
MDPI AG
Volume
8
Issue
1
Language
eng
Type
Article
This Version
VoR
Metadata
Show full item recordCitation
Fusco, F., Chudleigh, J., Holder, P., Bonham, J. R., Southern, K. W., Simpson, A., Moody, L., et al. (2022). Delivering Positive Newborn Screening Results: Cost Analysis of Existing Practice versus Innovative, Co-Designed Strategies from the ReSPoND Study.. Int J Neonatal Screen, 8 (1) https://doi.org/10.3390/ijns8010019
Abstract
Although the communication pathways of Newborn Bloodspot Screening (NBS) are a delicate task, these pathways vary across different conditions and are often not evidence-based. The ReSPoND interventions were co-designed by healthcare professionals alongside parents who had received a positive NBS result for their child. To calculate the cost of these co-designed strategies and the existing communication pathways, we interviewed 71 members of the clinical and laboratory staff of the 13 English NBS laboratories in the English National Health Service. Therefore, a scenario analysis was used to compare the cost of the existing communication pathways to the co-designed strategies delivered by (i) home-visits and (ii) telecommunications. On average, the existing communication pathway cost £447.08 per infant (range: £237.12 to £628.51) or £234,872.75 (£3635.99 to £1,932,986.23) nationally. Implementing the new interventions relying on home-visits exclusively would cost on average £521.62 (£312.84 to £646.39) per infant and £297,816.03 (£4506.37 to £2,550,284.64) nationally, or £447.19 (£235.79 to £552.03) and £231,342.40 (£3923.7 to £1,922,192.22) if implemented via teleconsultations, respectively. The new strategies delivered are not likely to require additional resources compared with current practice. Further research is needed to investigate whether this investment represents good value for money for the NHS budget.
Keywords
Genetics, Health Economics, Health Services Research
Sponsorship
National Institute for Health Research (NIHR) (16/52/25)
Identifiers
35323198, PMC8951105
External DOI: https://doi.org/10.3390/ijns8010019
This record's URL: https://www.repository.cam.ac.uk/handle/1810/336407
Statistics
Total file downloads (since January 2020). For more information on metrics see the
IRUS guide.
Recommended or similar items
The current recommendation prototype on the Apollo Repository will be turned off on 03 February 2023. Although the pilot has been fruitful for both parties, the service provider IKVA is focusing on horizon scanning products and so the recommender service can no longer be supported. We recognise the importance of recommender services in supporting research discovery and are evaluating offerings from other service providers. If you would like to offer feedback on this decision please contact us on: support@repository.cam.ac.uk